Cara A. Rabik

United States Food and Drug Administration

Also affiliated with Center for Drug Evaluation and Research

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Optimal fludarabine lymphodepletion is associated with improved outcomes after CAR T-cell therapy”.

Optimal fludarabine lymphodepletion is associated with improved outcomes after CAR T-cell therapy

Blood Advances(2021)10.1182/bloodadvances.2021006418

N/A

0DataRank · unranked

113 citations

Jaap Jan Boelens, Audrey Mauguen, Christina Baggott, Snehit Prabhu, Emily Egeler +27 more

Outcomes After Nonresponse and Relapse Post-Tisagenlecleucel in Children, Adolescents, and Young Adults With B-Cell Acute Lymphoblastic Leukemia

Journal of Clinical Oncology(2022)10.1200/jco.22.01076

N/A

0DataRank · unranked

73 citations

Anne Eaton, Christina Baggott, Jenna Rossoff, Snehit Prabhu, Amy K. Keating +26 more

FDA Approval Summary: Blinatumomab for the Treatment of B-Cell Precursor Acute Lymphoblastic Leukemia in the Consolidation Phase of Multiphase Chemotherapy

Clinical Cancer Research(2025)10.1158/1078-0432.ccr-25-1034

N/A

0DataRank · unranked

4 citations

Shu Wang, Ritu Chadda, Donna Przepiorka, Jonathon Vallejo, Xiling Jiang +3 more